Evidence map›Paper›PMID 17209015›Full record

ArticleJournal of bacteriology2007

Evidence for type III restriction and modification systems in Mycoplasma pulmonis.

Kevin Dybvig, Z Cao, C Todd French, Huilan Yu

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kevin DybvigDepartment of Genetics, 720 S. 20th St., KAUL 720, University of Alabama at Birmingham, Birmingham, AL 35294-0024, USA. dybvig@uab.edu
Z Cao
C Todd French
Huilan Yu
University of Alabama at Birmingham · US

Funding

Mechanisms of Mycoplasmal Disease PathogenesisR01AI063909 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DYBVIG, KEVIN F · 2005 to 2014
$3.0M
MECHANISMS OF MYCOPLASMA-INDUCED ARTHRITISR01AR044252 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DYBVIG, KEVIN F · 1997 to 2009
$2.4M
NIAID NIH HHS AI63909NIAID NIH HHS R01 AI063909NIAMS NIH HHS AR44252NIAMS NIH HHS R01 AR044252
6 · The paper itself

Abstract

Mycoplasma pulmonis possesses a cassette of genes that are predicted to code for type III restriction and modification (R-M) enzymes. Transposon disruption of a gene predicted to code for the endonuclease subunit of the enzyme resulted in loss of R-M activity. Genomic data indicate that the cassette was acquired by horizontal gene transfer and possibly located on a mobile element.

Indexed as

AnimalsDNA Restriction-Modification EnzymesDNA Transposable ElementsEndonucleasesGene Transfer, HorizontalMiceMutagenesis, InsertionalMycoplasma pulmonisPolymerase Chain ReactionTransformation, BacterialDNA Restriction-Modification EnzymesDNA Transposable ElementsEndonucleases

Identifiers

PMID17209015
PMCPMC1899405
OpenAlexW1977506790

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.